July 2014 FDA Recall Drug by Novartis Pharmaceuticals Corp.
D-1516-2014 - Failed Tablet/Capsule Specifications

This Class III drug recall was voluntarily initiated by Novartis Pharmaceuticals Corp. on July 30, 2014 for the product Drug. The FDA reported the reason for recall as failed tablet/capsule specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1516-2014

Reason for Recall
Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.
Initiated
07-30-2014
Reported
08-13-2014
Quantity
50 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Novartis Pharmaceuticals Corp.
Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by: Patheon Inc., Whitby Operations, Ontario, Canada L1N 5Z5; Distributed by: Novartis Pharmaceuticals Corp., East Hanover, New Jersey 07936; NDC 0078-0436-05, UPC 3 0078-0436-05 2.

Batch or Lot Expiration Information

Lot# PKTS, Exp 01/17